Altrova Health Inc.CSE: ROVA

Altrova Health Announces Closing of Financing

· Issued by Altrova Health Inc. via Newsfile

Summary by 6ix AI

Altrova Health Inc., a Canadian public company building a portfolio of health products, closed a non-brokered private placement (a share sale arranged directly with investors rather than through a broker) for total gross proceeds of C$669,840. The placement follows its news releases dated September 8, 2026.

Key details

  • The company issued 13,396,800 units at $0.05 per unit. Each unit is one common share and one warrant. Each whole warrant lets the holder buy one more common share at $0.06 for 36 months from issuance.
  • Altrova Health paid certain eligible finders (people or firms who introduced investors) cash commissions of C$21,958.30. It also issued them 439,166 finder's warrants, each exercisable for one unit at $0.05 for 36 months from the closing date.
  • PowerOne Capital Markets Limited acted as finder for a portion of the placement.
  • The company expects to use the net proceeds to implement and commercialize its exclusive U.S. distribution agreement with Reliability Funding LLC. Planned uses include product procurement and initial inventory, customer onboarding, training, marketing and sales, plus general corporate and working capital purposes.

6ix AI wrote this summary from the release below and checked it against the release.

Toronto, Ontario--(Newsfile Corp. - October 13, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") is pleased to announce that, further to its news releases dated September 8, 2026, it has closed its non-brokered private placement (the "Offering") for total gross proceeds of C$669,840. Gross proceeds were raised through the issuance of 13,396,800 units (the "Units") at a price of $0.05 per Unit.

Each Unit consists of one common share of the Company (each, a "Common Share") and one warrant. Each whole warrant (each, a "Warrant") entitles the holder to purchase one additional Common Share at an exercise price of $0.06 per share for a period of 36 months from the date of issuance. In connection with the Offering, the Company paid to certain eligible finders (each, a "Finder") cash commissions of C$21,958.30 and issued 439,166 Finder's warrants, in accordance with applicable securities laws and CSE policies. Each Finder's warrant will entitle the holder to acquire one additional Unit at an exercise price of $0.05 per Unit for a period of 36 months from the closing date of the Offering. PowerOne Capital Markets Limited acted as finder in connection with a portion of the Offering.

The net proceeds of the Offering are expected to be used to implement and commercialize the Company's exclusive U.S. distribution agreement with Reliability Funding LLC, including product procurement and initial inventory, customer onboarding, training, marketing and sales activities, and for general corporate and working capital purposes.

"With this financing closed, we can move on executing our exclusive U.S. distribution agreement with Reliability," said Geoff Benic, Chief Executive Officer of Altrova Health. "The proceeds will put inventory, onboarding and sales support in place so we can start working toward commercial traction in the U.S. market. We thank our shareholders and investors for their support."

About Altrova Health Inc.

Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment and wellness. The Company's strategy is focused on assembling products, technologies and strategic capabilities designed to address evolving market needs and support long-term growth.

For additional information, please contact:
Geoff Benic
Chief Executive Officer
Altrova Health Inc.
Email: geoff@altrovahealth.com
Phone: +1 647-880-7314
Website: www.altrovahealth.com

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws. Forward-looking statements are based on current expectations, estimates, projections, and assumptions made by the Company in light of its experience and perception of historical trends, current conditions, and anticipated future developments, as well as other factors the Company believes are appropriate in the circumstances.

Forward-looking statements in this release include, but are not limited to the use of proceeds of the proposed private placement Offering.

Forward-looking statements are inherently subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to risk general economic, market, and industry conditions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release.

Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. All forward-looking statements contained in this release are expressly qualified by this cautionary statement.

Not for distribution to United States Newswire Services or for dissemination in the United States.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318631

Source: Altrova Health Inc.

View original source (Newsfile)Altrova Health Inc. on 6ix

Earlier from Altrova Health

All Altrova Health news releases